BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8326016)

  • 1. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.
    Olson LK; Redmon JB; Towle HC; Robertson RP
    J Clin Invest; 1993 Jul; 92(1):514-9. PubMed ID: 8326016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator.
    Poitout V; Olson LK; Robertson RP
    J Clin Invest; 1996 Feb; 97(4):1041-6. PubMed ID: 8613527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.
    Robertson RP; Zhang HJ; Pyzdrowski KL; Walseth TF
    J Clin Invest; 1992 Aug; 90(2):320-5. PubMed ID: 1644911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression.
    Olson LK; Sharma A; Peshavaria M; Wright CV; Towle HC; Rodertson RP; Stein R
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9127-31. PubMed ID: 7568086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.
    Sharma A; Olson LK; Robertson RP; Stein R
    Mol Endocrinol; 1995 Sep; 9(9):1127-34. PubMed ID: 7491105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15.
    Moran A; Zhang HJ; Olson LK; Harmon JS; Poitout V; Robertson RP
    J Clin Invest; 1997 Feb; 99(3):534-9. PubMed ID: 9022089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose rapidly and reversibly decreases INS-1 cell insulin gene transcription via decrements in STF-1 and C1 activator transcription factor activity.
    Olson LK; Qian J; Poitout V
    Mol Endocrinol; 1998 Feb; 12(2):207-19. PubMed ID: 9482663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity.
    Harmon JS; Tanaka Y; Olson LK; Robertson RP
    Diabetes; 1998 Jun; 47(6):900-4. PubMed ID: 9604866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47.
    Lu M; Seufert J; Habener JF
    J Biol Chem; 1997 Nov; 272(45):28349-59. PubMed ID: 9353292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin.
    Redmon JB; Towle HC; Robertson RP
    Diabetes; 1994 Apr; 43(4):546-51. PubMed ID: 7907998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of insulin gene expression by glucose.
    Goodison S; Kenna S; Ashcroft SJ
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):563-8. PubMed ID: 1322137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.
    Redmon JB; Olson LK; Armstrong MB; Greene MJ; Robertson RP
    J Clin Invest; 1996 Dec; 98(12):2786-93. PubMed ID: 8981925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15.
    Gleason CE; Gonzalez M; Harmon JS; Robertson RP
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E997-1002. PubMed ID: 11052953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable regulation by insulin of insulin gene expression in HIT-T15 cells.
    Zhang HJ; Petersen B; Robertson RP
    Diabetologia; 1994 Jun; 37(6):559-66. PubMed ID: 7926339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells.
    Watada H; Kajimoto Y; Umayahara Y; Matsuoka T; Kaneto H; Fujitani Y; Kamada T; Kawamori R; Yamasaki Y
    Diabetes; 1996 Nov; 45(11):1478-88. PubMed ID: 8866550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration.
    Jacqueminet S; Briaud I; Rouault C; Reach G; Poitout V
    Metabolism; 2000 Apr; 49(4):532-6. PubMed ID: 10778881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of HES-1, BETA2/NeuroD, and PDX-1 is involved in impaired insulin synthesis induced by glucocorticoids in HIT-T15 cells.
    Shinozuka Y; Okada M; Oki T; Sagane K; Mizui Y; Tanaka I; Katayama K; Murakami-Murofushi K
    Biochem Biophys Res Commun; 2001 Sep; 287(1):229-35. PubMed ID: 11549279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to glucose of transcription factor binding to the rat insulin-1 gene promoter.
    Goodison S; Miyazaki J; Ashcroft SJ
    Biochem Biophys Res Commun; 1994 Aug; 203(1):702-10. PubMed ID: 8074725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
    Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
    EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells.
    Lawrence MC; Bhatt HS; Watterson JM; Easom RA
    Mol Endocrinol; 2001 Oct; 15(10):1758-67. PubMed ID: 11579208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.